Clarinex during pregnancy: is it safe?

What does the evidence say about clarinex during pregnancy?

1. Loratadine is not expected to raise the chance of birth defects above the general population's baseline of about 3%, and a study of 163 first-trimester loratadine exposures found no increased miscarriage risk; since desloratadine (Clarinex) is loratadine's active breakdown product, that reassuring pattern is generally extended to desloratadine as well. 1
2. Desloratadine is the active metabolite loratadine breaks down into in the liver, with a longer half-life of about 28 hours compared with loratadine's roughly 8 hours, and available data describes loratadine and cetirizine as among the best-studied second-generation antihistamines, generally considered safe for allergic rhinitis during pregnancy. 2
3. A large study screening 364 antihistamine-defect combinations found results generally consistent with no association between birth defects and antihistamine use in early pregnancy, and specifically found no link between loratadine and hypospadias, a concern raised by earlier, smaller research. 3
4. Because milk levels haven't been directly measured for desloratadine itself, LactMed estimates exposure using loratadine data: after a single 40 mg loratadine dose, peak breast milk levels of the desloratadine metabolite averaged 16 mcg per liter, working out to a maximum expected infant dose of about 0.42% of the mother's weight-adjusted dose. 4
5. LactMed concludes maternal desloratadine use is unlikely to affect a breastfed infant or milk production given its expected low milk levels and lack of sedating effects, though it flags a possible negative effect on milk supply specifically when combined with a decongestant like pseudoephedrine, as in Clarinex-D. 4

Is clarinex safe in each trimester?

• First trimester. Loratadine's reassuring first-trimester data, no higher rate of birth defects and no link to hypospadias in the largest study, is generally extended to desloratadine since it's loratadine's active form, though direct human studies on desloratadine itself remain limited.
• Second trimester. Desloratadine's longer half-life, about 28 hours compared with loratadine's roughly 8, means once-daily dosing covers allergy symptoms through the day without needing a repeat dose.
• Third trimester. If your product is Clarinex-D rather than plain Clarinex, that combination includes a decongestant, which carries its own separate pregnancy considerations. Check with your provider before using a combination product close to delivery.